Chicago Capital Management, LLC
In its 13F for Q2 2026 (holdings as of June 30, 2026, filed July 22, 2026), Chicago Capital Management, LLC reported 12 stock positions worth $48.4 million. Its top holding was Nuvalent Class A (NUVL) at 22.8% of the portfolio, followed by Apogee Therapeutics (APGE, 20.2%) and Chart Industries (GTLS, 17.3%). Compared with Q1 2026, it opened 10 new positions and sold out of 10. The biggest buy was a new position in Nuvalent Class A (NUVL) and the biggest sale an exit from Janus Henderson (JHG).
- Most Recent 13F
- Q2 2026
- Location
- CHICAGO, IL
- CIK
- 0001580162
- Portfolio Value
- $48.4M (Q2 2026)
- SEC Filing
- 0001062993-26-003767 ↗ filed Jul 22, 2026
Holdings Value
Holdings 12 stocks · $48.4M
| NUVL Nuvalent Inc. Class A | 22.82% | 115,500 | $11.1M | New |
| APGE Apogee Therapeutics Inc. | 20.25% | 97,100 | $9.8M | New |
| GTLS Chart Industries Inc. | 17.25% | 53,000 | $8.4M | No change |
| TMHC Taylor Morrison Home Corp. | 14.81% | 133,000 | $7.2M | New |
| CPRX Catalyst Pharmaceuticals Inc. | 6.05% | 122,650 | $2.9M | New |
| ALOT Astronova Inc. | 5.88% | 131,100 | $2.8M | New |
| ESPR Esperion Therapeutics Inc. | 5.38% | 830,935 | $2.6M | New |
| TECH Bio-Techne Corp. | 4.16% | 37,509 | $2.0M | New |
| TBRG Trubridge Inc. | 1.42% | 34,663 | $686K | New |
| STEL Stellar Bancorp Inc. | 0.71% | 11,559 | $342K | New |
| EA Electronic Arts Inc. | 0.64% | 2,000 | $309K | No change |
| NSTS NSTS Bancorp Inc. | 0.63% | 29,020 | $304K | New |
Other holdings (15): bonds, preferreds, convertibles and warrants · $16.7M (not counted above)
| Security | Class | Shares / Principal | Value | Change |
|---|---|---|---|---|
| MGP INGREDIENTS INC (MGPI 1.875 11/15/41) | NOTE 1.875%11/1 · principal | 6,068 | $5.9M | Add +0.8% |
| ETSY INC (ETSY 0.25 06/15/28) | NOTE 0.250% 6/1 · principal | 4,292 | $3.9M | No change |
| HP ENTERPRISE CO (HPE 7.625 09/01/27) | 7.625 MAND CONV | 32,900 | $3.8M | No change |
| SAREPTA THERAPEUTICS INC (SRPT 1.25 09/15/27) | NOTE 1.250% 9/1 · principal | 3,170 | $3.0M | New |
| XRXDW Xerox Holdings Corp. | *W EXP 02/11/202 | 95,980 | $26K | New |
| BANDWIDTH INC (BAND 0.5 04/01/28) | NOTE 0.500% 4/0 · principal | 8,153 | $8K | Add +0.2% |
| SABRE GLBL INC (SABHLD 7.32 08/01/26) | NOTE 7.320% 8/0 · principal | 6,904 | $7K | Add +15.9% |
| RAPID7 INC (RPD 0.25 03/15/27) | NOTE 0.250% 3/1 · principal | 6,520 | $6K | Add +44.3% |
| VERITONE INC (VERI 1.75 11/15/26) | NOTE 1.750%11/1 · principal | 5,500 | $5K | Add +120.0% |
| AMPHASTAR PHARMACEUTICAL (AMPH 2 03/15/29) | NOTE 2.000% 3/1 · principal | 5,440 | $5K | New |
| THE REALREAL INC (REAL 1 03/01/28) | NOTE 1.000% 3/0 · principal | 5,307 | $5K | No change |
| FIVE9 INC (FIVN 1 03/15/29) | NOTE 1.000% 3/1 · principal | 5,000 | $4K | New |
| SHAKE SHACK INC (SHAK 0 03/01/28) | NOTE 3/0 · principal | 4,189 | $4K | No change |
| XEROX HOLDINGS CORP (XRX 3.75 03/15/30) | NOTE 3.750% 3/1 · principal | 4,000 | $1K | No change |
| PAR TECHNOLOGY CORP (PAR 1.5 10/15/27) | NOTE 1.500%10/1 · principal | 1,127 | $1K | No change |
Total filed on the 13F, all lines: $65.2M.
Portfolio Sells Q1 2026 → Q2 2026
| JHG Janus Henderson Group PLC | Sold out | 0.00% | −17.37 |
| ACLX Arcellx Inc. | Sold out | 0.00% | −16.99 |
| FOLD Amicus Therapeutics Inc. | Sold out | 0.00% | −15.28 |
| APLS Apellis Pharmaceuticals Inc. | Sold out | 0.00% | −12.18 |
| TERN Terns Pharmaceuticals Inc. | Sold out | 0.00% | −10.86 |
| DHIL Diamond Hill Investment Grp | Sold out | 0.00% | −3.09 |
| BLFY Blue Foundry Bancorp | Sold out | 0.00% | −3.07 |
| THR Thermon Group Holdings Inc. | Sold out | 0.00% | −2.42 |
| DAWN Day One Biopharmaceuticals I | Sold out | 0.00% | −0.34 |
| HTBK Heritage Commerce Corp. | Sold out | 0.00% | −0.28 |
Portfolio Buys Q1 2026 → Q2 2026
| NUVL Nuvalent Inc. Class A | New | 22.82% | +22.82 |
| APGE Apogee Therapeutics Inc. | New | 20.25% | +20.25 |
| TMHC Taylor Morrison Home Corp. | New | 14.81% | +14.81 |
| CPRX Catalyst Pharmaceuticals Inc. | New | 6.05% | +6.05 |
| ALOT Astronova Inc. | New | 5.88% | +5.88 |
| ESPR Esperion Therapeutics Inc. | New | 5.38% | +5.38 |
| TECH Bio-Techne Corp. | New | 4.16% | +4.16 |
| TBRG Trubridge Inc. | New | 1.42% | +1.42 |
| STEL Stellar Bancorp Inc. | New | 0.71% | +0.71 |
| NSTS NSTS Bancorp Inc. | New | 0.63% | +0.63 |
Notes & Other Activity Q1 2026 → Q2 2026
| CRACKER BARREL OLD COUNT (CBRL 0.625 06/15/26) | NOTE 0.625% 6/1 · principal | Sold out | 6,883 | $6.8Mbefore exit |
| MGP INGREDIENTS INC (MGPI 1.875 11/15/41) | NOTE 1.875%11/1 · principal | Add +0.8% | 6,068 | $5.9M |
| SAREPTA THERAPEUTICS INC (SRPT 1.25 09/15/27) | NOTE 1.250% 9/1 · principal | New | 3,170 | $3.0M |
| XRXDW Xerox Holdings Corp. | *W EXP 02/11/202 | New | 95,980 | $26K |
| BANDWIDTH INC (BAND 0.5 04/01/28) | NOTE 0.500% 4/0 · principal | Add +0.2% | 8,153 | $8K |
| SABRE GLBL INC (SABHLD 7.32 08/01/26) | NOTE 7.320% 8/0 · principal | Add +15.9% | 6,904 | $7K |
| IRONWOOD PHARMACEUTICALS (IRWD 1.5 06/15/26) | NOTE 1.500% 6/1 · principal | Sold out | 7,000 | $7Kbefore exit |
| RAPID7 INC (RPD 0.25 03/15/27) | NOTE 0.250% 3/1 · principal | Add +44.3% | 6,520 | $6K |
| ACCURAY INC (ARAY 3.75 06/01/26) | NOTE 3.750% 6/0 · principal | Sold out | 6,500 | $6Kbefore exit |
| VERITONE INC (VERI 1.75 11/15/26) | NOTE 1.750%11/1 · principal | Add +120.0% | 5,500 | $5K |
| AMPHASTAR PHARMACEUTICAL (AMPH 2 03/15/29) | NOTE 2.000% 3/1 · principal | New | 5,440 | $5K |
| FIVE9 INC (FIVN 1 03/15/29) | NOTE 1.000% 3/1 · principal | New | 5,000 | $4K |
| NABORS INDUSTRIES INC (NBR 1.75 06/15/29) | NOTE 1.750% 6/1 · principal | Sold out | 4,550 | $4Kbefore exit |
| LITHIUM ARGENTINA AG (LARCN 1.75 01/15/27) | NOTE 1.750% 1/1 · principal | Sold out | 3,820 | $4Kbefore exit |
| ASSERTIO HOLDINGS INC (ASRT 6.5 09/01/27) | NOTE 6.500% 9/0 · principal | Sold out | 2,750 | $3Kbefore exit |
Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 12 | $48.4M | NUVL, APGE, GTLS, TMHC, CPRX |
| Q1 2026 | 12 | $47.3M | GTLS, JHG, ACLX, FOLD, APLS |
| Q4 2025 | 18 | $49.6M | CDTX, EXAS, JHG, CFLT, ATXS |
| Q3 2025 | 6 | $24.7M | VRNA, TRML, PBBK, CCRD, CFSB |
| Q2 2025 | 14 | $39.8M | SWTX, BPMC, OPOF, VIGL, PWOD |
| Q1 2025 | 14 | $44.0M | ITCI, FNA, CCRN, PDCO, EVBN |
| Q4 2024 | 15 | $42.8M | HTLF, EVBN, CCRN, AE, FFNW |
| Q3 2024 | 9 | $39.4M | HTLF, ENV, HAYN, RCM, FFNW |
| Q2 2024 | 11 | $27.5M | HAYN, HTLF, SILK, MCBC, WIRE |
| Q1 2024 | 12 | $20.0M | PXD, FUSN, CSTR, NWLI, CERE |